https://www.selleckchem.com/pr....oducts/abraxane-nab-
ilepsia published by Wiley Periodicals, Inc. on behalf of International League Against Epilepsy.BACKGROUND AND AIMS Tools to detect type 1 diabetes (T1D) individuals at overt cardiovascular disease (CVD) risk are scarce. We aimed to assess the usefulness of the score 'Steno Type 1 Risk Engine' (Steno-Risk) to identify T1D patients with advanced carotid atherosclerosis. MATERIAL AND METHODS T1D patients without CVD with at least one of the following were included ≥40 years, diabetic nephropathy, or diabetes duration ≥10 y
Like
Comment
Share
